Magnetic Resonance-Guided Laser Interstitial Thermal Therapy for Brain Metastases Trial

NACompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

January 11, 2022

Primary Completion Date

February 20, 2025

Study Completion Date

June 11, 2025

Conditions
Brain Metastasases
Interventions
DEVICE

Laser interstitial thermal therapy

The LITT procedure was performed using the LS1 laser ablation system and SR1 stereotactic robotic system (Sinovation, Beijing, China). The ablation system was equipped with a 980-nm laser with a maximum of 15 W of power, a core silica fiber optic with a 1.8-mm diameter cooling catheter, and a cooling pump to make saline flow into and out through the catheter. The optic and catheter approaches were planned with the preoperative simulation software (Sinovation, Beijing, China) using the preoperative T1-weighted MRI scan, and passing through important cerebral vascular and functional zones was avoided。. The catheter was implanted by neurosurgeons under stereotactic guidance, and a laser probe was inserted through the catheter. After LITT, a T1-weighted intraoperative MRI scan was performed to confirm the effect of ablation. The ablation rate was calculated by another neurosurgeon who did not participate in the study.

Trial Locations (6)

Unknown

Beijing Tiantan Hospital, Capital Medical University, Beijing

The First Affiliated Hospital of Fujian Medical University, Fuzhou

The First Affiliated Hospital of Sun Yat-sen University, Guangzhou

First Affiliated Hospital of Zhengzhou University, Zhengzhou

Jilin University-China-Japan Friendship Hospital, Changchun

Huashan Hospital, Shanghai

All Listed Sponsors
collaborator

Sinovation (Beijing) Medical Technology

UNKNOWN

lead

Beijing Tiantan Hospital

OTHER